SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Intuitive Machines, Inc. is a space exploration, infrastructure, and services company, which engages in contributing to the establishment of cislunar infrastructure and helping to develop cislunar and deep space commerce. It offers space products and services. The company was founded by Stephen J. Altemus, Kam Ghaffarian, and Timothy P. Crain in 2013 and is headquartered in Houston, TX.

Intuitive Machines Inc - Ordinary Shares - Class A

Intuitive Machines Inc

Intuitive Machines is experiencing extreme volatility following a mixed earnings report that featured record revenue and a massive backlog but missed consensus expectations for profitability. While the community is sharply divided between retail bulls focused on long-term backlog potential and skeptics citing concerns over cash burn and dilution, the stock's ability to quickly rebound from a steep pre-market sell-off has become the primary talking point.

NIKE, Inc. engages in the design, development, marketing, and sale of athletic footwear, apparel, accessories, equipment, and services. It operates through the following segments: North America, Europe, Middle East, and Africa (EMEA), Greater China, Asia Pacific and Latin America (APLA), Global Brand Divisions, Converse, and Corporate. The North America, EMEA, Greater China, and APLA segments refer to the design, development, marketing, and selling of athletic footwear, apparel, and equipment. The Global Brand Divisions segment represents its NIKE Brand licensing businesses. The Converse segment designs, markets, licenses, and sells casual sneakers, apparel, and accessories. The Corporate segment is composed of unallocated general and administrative expenses. The company was founded by William Jay Bowerman and Philip Hampson Knight on January 25, 1964 and is headquartered in Beaverton, OR.

Nike, Inc. - Ordinary Shares - Class B

Nike Inc

Nike continues to face significant pressure as analysts weigh in on earnings, sparking widespread debate among the community regarding whether the current stock price represents a deep value turnaround play or a long-term trap. Investors are closely monitoring the stock's stability around the forty-dollar floor while debating if tariff-related tailwinds and potential management shifts will be sufficient to overcome ongoing concerns about brand momentum and competitive market share.

Oscar Health, Inc. is a healthcare insurance company, which serves its customers through a technology platform. It offers individual and family, small group and medicare advantage plans, and technology platform to others within the provider and payor space. The company was founded by Mario Tobias Schlosser, Kevin Nazemi, and Joshua Kushner on October 25, 2012 and is headquartered in New York, NY.

Oscar Health Inc - Ordinary Shares - Class A

Oscar Health is experiencing significant bullish momentum driven by record profitability, aggressive membership growth, and a raised 2026 earnings outlook that has fundamentally shifted the market's perception of the company. Investors are actively discussing the stock's transition from a turnaround play to a growth leader, with the community closely tracking institutional accumulation, the potential for further margin expansion, and the long-term impact of its proprietary tech platform.

Fundrise Innovation Fund LLC operates as a non-diversified, closed-end management investment company. It invests in growing tech companies to help them expand and generate profits. The company was founded on June 7, 2021 and is headquartered in Washington, DC.

Fundrise Innovation Fund LLC. - Common Shares of Limited Liability Company Interests

Fundrise Innovation Fund 

VCX is experiencing significant volatility as investors debate the impact of an accelerated lockup expiration, which has increased share supply and put downward pressure on the fund's premium to its net asset value (NAV). The community remains sharply divided, with bulls pointing to the fund's exposure to high-profile private AI and space companies as long-term catalysts, while bears warn that the stock remains overvalued compared to its underlying asset base.

Johnson & Johnson is a holding company, which engages in the research, development, manufacture, and sale of products in the healthcare field. It operates through the Innovative Medicine and MedTech segments. The Innovative Medicine segment focuses on immunology, infectious diseases, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The MedTech segment includes a portfolio of products used in interventional solutions, orthopaedics, surgery, and vision categories. The company was founded by Robert Wood Johnson I, James Wood Johnson, and Edward Mead Johnson Sr. in 1887 and is headquartered in New Brunswick, NJ.

Johnson & Johnson

Johnson & Johnson remains a focal point for investors as it balances robust quarterly performance and a strong oncology pipeline against ongoing legal risks from talc litigation. Community sentiment reflects a mix of confidence in its long-term healthcare leadership and defensive stability, alongside active speculation regarding its M&A strategy to secure dominance in the oncology space.

Sovereign frontier cloud for AI that builds  AI agents are starting to build and operate real software. Agentic organizations are starting to coordinate people, code, data, payments, and governance. Both need a cloud that is sovereign, tamperproof, and always on.  The Internet Computer is that cloud.  Built on more than USD 500 million in R&amp;D, ICP uses advanced blockchain technology and cryptography to run entire software systems end-to-end on the network: websites, apps, services, data, payments, and governance. Code and data are protected by the protocol, replicated across independent nodes, and cannot be silently changed by a cloud provider, backend operator, or attacker.  Cloud engines make this infrastructure sovereign. They let organizations run ICP-powered compute across chosen providers, locations, and jurisdictions while keeping the same tamperproof and always-on guarantees of the network.  This is the real demand ICP serves: sovereign frontier cloud for AI agents and agentic organizations. Agents can build and update software. Organizations can run rules, assets, and governance as verifiable systems. The result is software that stays online, keeps its data, and remains under the control of its owners.  Developers and AI agents can build on the Internet Computer with any AI assistant using the ICP skill library at skills.internetcomputer.org, or by creating apps through conversation with Caffeine AI.  Computation on ICP is paid for by converting $ICP into cycles. $ICP is also used for staking and governance through the Network Nervous System.

Internet Computer

Internet Computer (ICP) is attracting significant attention as investors shift toward projects with tangible AI infrastructure and decentralized cloud utility rather than just speculative narratives. The community is actively debating the project's long-term potential to serve as a sovereign, on-chain cloud alternative while closely monitoring institutional integrations and developments in the broader decentralized AI ecosystem.

The Wendy’s Co. engages in operating, developing, and franchising a system of quick-service restaurants. It operates through the following segments: Wendy’s U.S., Wendy’s International, and Global Real Estate and Development. The Wendy’s U.S. segment includes the operation and franchising of Wendy’s restaurants in the U.S. The Wendy’s International segment is involved in the operation and franchising of Wendy’s restaurants in countries and territories other than the U.S. The Global Real Estate and Development segment focuses on real estate activity for owned sites and sites leased from third parties. The company was founded by R. David Thomas on November 15, 1969 and is headquartered in Dublin, OH.

Wendy`s Co - Ordinary Shares - Class A

Wendy's Co

Wendy's is trending as investors and community members speculate on a potential take-private bid from Nelson Peltz's Trian Fund Management, fueling expectations of a premium buyout offer. The stock's high short interest has retail traders aggressively discussing a possible short squeeze, as they debate the potential offer price and advocate for buying and holding shares to maintain pressure on short sellers.

Aehr Test Systems engages in the design, manufacture, market, and sale of test and burn-in equipment used in the semiconductor industry. Its products include FOX-XP, FOX-NP, and FOX-CP wafer contact parallel test and burn-in systems, the WaferPak full wafer contactor, the DiePak Carrier, the WaferPak Aligner, the DiePak Autoloader, and test fixtures. The company was founded by Rhea J. Posedel on May 25, 1977 and is headquartered in Fremont, CA.

Aehr Test Systems

Aehr Test Systems is seeing intense volatility and high trading volume following a strong earnings report that showcased aggressive revenue growth forecasts and significant order backlogs. While the company's fiscal outlook has attracted institutional interest and positive analyst coverage, the stock is experiencing significant friction as investors grapple with its high valuation and the potential for a secondary share offering.

Ouster, Inc. engages in the provision of high resolution digital lidar sensors that offer advanced 3D vision to machinery, vehicles, robots, and fixed infrastructure assets. The company was founded by Angus Pacala and Mark Frichtl on June 30, 2015 and is headquartered in San Francisco, CA.

Ouster Inc - Ordinary Shares - Class A

Ouster Inc. is seeing intense community debate following a recent equity offering priced at $55, which has left investors questioning the stock's sharp pullback to current levels. While some traders view the decline as an opportunity to accumulate, many are highlighting the need for Ouster to demonstrate consistent Rev8 production scaling and contract execution to stabilize sentiment.

REalloys, Inc. is engaged in the rebuilding of domestic supply chain resilience for rare earth elements and magnets. It is involved in recycling, mining, oxide production, metallization, alloying, and magnet manufacturing. The company was founded on October 4, 2011 and is headquartered in Boca Raton, FL.

REalloys Inc.

REalloys Inc. is trending as community members closely watch its strategic U.S. Army partnership for critical mineral processing, with discussions heavily focused on the company's positioning ahead of upcoming regulatory deadlines for domestic supply chain independence. While some investors are accumulating shares, citing potential long-term growth and short squeeze dynamics, others are expressing concern over recent price volatility and the lack of immediate updates following the company's latest funding round.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Ben Sousa Executes Sell Order: Offloads $401K In ICU Medical Stock

A substantial insider sell was reported on August 12, by Ben Sousa, Chief Information Officer at ICU Medical (NASDAQ:ICUI), based on the recent SEC filing.
What Happened: After conducting a thorough analysis, Sousa soldread more...

ICU Medical Analysts Boost Their Forecasts Following Upbeat Q2 Earnings

ICU Medical Inc (NASDAQ:ICUI) reported strong Q2 earnings of $2.37 per share and raised its FY2026 guidance. Analysts have increased price targets for the stock.read more...

ICU Medical (ICUI) Reports Q2 Earnings: What Key Metrics Have to Say

While the top- and bottom-line numbers for ICU Medical (ICUI) give a sense of how the business performed in the quarter ended June 2026, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.

ICU Medical (ICUI) Tops Q2 Earnings and Revenue Estimates

ICU Medical (ICUI) delivered earnings and revenue surprises of +24.08% and +2.33%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Bio-Rad Laboratories (BIO) Beats Q2 Earnings Estimates

Bio-Rad (BIO) delivered earnings and revenue surprises of +11.97% and -0.97%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America

Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America PR Newswire AUSTIN, Texas, July 9, 2026 This expansion of IV solutions manufacturing will help...

ICUI vs. SYK: Which Stock Should Value Investors Buy Now?

ICUI vs. SYK: Which Stock Is the Better Value Option?

ICUI or MDLN: Which Is the Better Value Stock Right Now?

ICUI vs. MDLN: Which Stock Is the Better Value Option?

This ICU Medical Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Top Wall Street analysts changed outlook on top names. Find all rating changes on Benzinga's analyst ratings page. See analyst views on ICUI, BDSX,.read more...

ICU Medical (ICUI) Strengthens Amid Competitors' Quality Issues

ICU Medical (ICUI) Strengthens Amid Competitors' Quality Issues...

$ICUI Q2 '26 Earnings Results & Recap

• Reported GAAP EPS of $0.76 down -46.85% YoY
• Reported revenue of $551.68M up 0.51% YoY
• For Fiscal Year 2026, ICU Medical, Inc. is updating its estimates of GAAP net income to a range of $73 million to $83 million and Adjusted EBITDA to $415 million to $435 million.

ICU Medical, Inc. engages in the provision of innovative medical products used in infusion therapy and critical care applications. Its product portfolio includes IV smart pumps, sets, connectors, closed system transfer devices for hazardous drugs, sterile IV solutions, cardiac monitoring systems, along with pain management and safety software technology designed to help meet clinical, safety and workflow goals. The company was founded by George A. Lopez in 1984 and is headquartered in San Clemente, CA.

ICU Medical, Inc.

Bullish Sentiment

Up more than 1% 

Flat to up 1%

Flat to down 1%

Down more than 1%

The S&P 500 ($SPY) is headed towards a winning week. What do you think the index's return will look like next week? Vote and explain your reasoning in the comments.

What do you think the S&amp;P 500&#39;s ($SPY) return will be next week?

Current Price	$182.98
Prev Close	$183.11
Open	$182.25
Dividend Yield	0.00%
50-Day Moving Average	$156.07
Beta	1.17
Avg. Volume	282,688.26
PE Ratio	154.57

52-Week High	$192.85
52-Week Low	$112.50
Market Capitalization	$4.58B
EPS (Annual)	$0.0294
Price to Book	2.13
Revenue Per Employee	$171,540.39

Feed

News

Sentiment

Earnings

Fundamentals

Info